Clinical Trial Update: Radioimmunoimaging of AL Amyloidosis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating radioimmunoimaging for AL amyloidosis has completed, sponsored by the University of Tennessee.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• Radioimmunoimaging agent for AL amyloidosis (unspecified)

Snippet

Sponsor: University of Tennessee | Conditions: AL Amyloidosis | Phase 1 | Status: COMPLETED